業績

Yanagiya S, Nakamura K, Ukawa S, Tsutsumi A, Atsumi T, Tamakoshi A.

Household income and the risk of incident hypertension in employees at multiple workplaces in Japan: J-HOPE.

Hypertens Res. 2020 Aug 24.

IF：2.941 (2019)

Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Thrombomodulin as a physiological modulator of intravascular injury. Frontiers in Immunology (in press)

IF：5.085 (2019)

Fujieda Y, Horita T, Nishimoto N, Tanimura K, Amasaki Y, Kasahara H, Furukawa S, Takeda T, Fukaya S, Matsui K, Tsutsumi A, Furusaki A, Sagawa A, Katayama K, Takeuchi K, Katsuumata K, Kurita T, Shane P, Kato M, Oku K, Yasuda S, Takahata M, Iwasaki N and Atsumi T Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study)

: a multicentre, double-blind, randomized, placebo-controlled trial.

Modern Rheumatology (IF 1.78)

第25回日本血栓止血学会学術奨励賞　久田諒先生

2020年度日本肺高血圧・肺循環学会学会奨励賞臨床研究賞　加藤　将先生

Chiho Oba-Yamamoto, Jun Takeuchi, Akinobu Nakamura, Ryoko Takikawa, Ayano Ozaki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia J Diabetes Investig, in press

IF: 3.761

Kato M*, Hattori T, Shimizu T, Ninagawa K, Izumihara R, Nomoto H, Tanimura K, Atsumi T.

Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation: A family report Journal of Bone and Mineral Metabolism. in press (*: Correspondence).

IF：2.297

Nobuya Abe and Yuichiro Fujieda.

Chronic active Epstein-Barr virus infection.

Blood. 2020; in press.

IF 17.543

Nakazawa D and Ishizu A.

Immunothrombosis in Severe COVID-19.

EBioMedicine. in press

IF 6.490

OgataY, Fujieda Y, Sugawara M, Sato T, Ohnishi N, Kono M, Kato M, Oku K, Amengual O, Atsumi T Morbidity and mortality in antiphospholipid syndrome based on cluster

analysis: a 10-year longitudinal cohort study Rheumatology

IF:5.245